A7101658
BisphenolA(3-chloro-2-hydroxypropyl)(2,3-dihydroxypropyl)ether , 10mMinDMSO , 227947-06-0
Synonym(s):
3-[4-[1-[4-(3-Chloro-2-hydroxypropoxy)phenyl]-1-methylethyl]phenoxy]-1,2-propanediol;EPI 001
CAS NO.：227947-06-0
Empirical Formula: C21H27ClO5
Molecular Weight: 394.89
MDL number: MFCD02683414
EINECS: 200-258-5
| Pack Size | Price | Stock | Quantity |
| 1ml | RMB559.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 67 °C |
| Boiling point: | 601.0±55.0 °C(Predicted) |
| Density | 1.228±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | DMSO: soluble15mg/mL, clear |
| pka | 13.13±0.20(Predicted) |
| form | powder |
| color | white to beige |
| InChI | InChI=1S/C21H27ClO5/c1-21(2,15-3-7-19(8-4-15)26-13-17(24)11-22)16-5-9-20(10-6-16)27-14-18(25)12-23/h3-10,17-18,23-25H,11-14H2,1-2H3 |
| InChIKey | HDTYUHNZRYZEEB-UHFFFAOYSA-N |
| SMILES | C(O)C(O)COC1=CC=C(C(C2=CC=C(OCC(O)CCl)C=C2)(C)C)C=C1 |
Description and Uses
EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator that inhibits androgen receptor expression and activity in prostate cancer. It is a novel androgen receptor antagonists that has the potential for treating prostate cancer.
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P305+P351+P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| WGK Germany | 3 |
| HS Code | 29072300 |
